Pulse Waveform Analysis for Hypovolemic Hypotension Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring cardiac bradycardia, particularly in hypovolemic conditions, are limited as they primarily rely on electrocardiography (ECG) which does not provide comprehensive hemodynamic information, and existing pulse oximeters cannot capture cardiac electrophysiology signals, making it difficult to detect pre-symptomatic bradycardia and its hemodynamic impacts.
Innovation Solution
A system and method that utilize a computing device to analyze pulse rate and strength metrics from arterial pulse waveforms, comparing them to baselines to predict hypovolemic hypotensive conditions by identifying anomalous pulse rate and strength differences, integrating this analysis with pulse oximeter data to provide real-time hemodynamic monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ECG is used to monitor cardiac bradycardia, then cardiac electrophysiology signals can be captured, but comprehensive hemodynamic information is not provided
Solution Approach 1:
The patent combines ECG electrodes with pulse oximeter functionality into an integrated monitoring system. The ECG electrodes capture cardiac electrophysiology signals while the pulse oximeter component provides hemodynamic information including pulse rate, pulse strength, and tissue perfusion metrics, thereby resolving the information loss limitation of standalone ECG monitoring
Solution Approach 2:
The monitoring system is designed to perform multiple functions simultaneously: it detects cardiac arrhythmias through ECG signals, monitors hemodynamic status via pulse waveform analysis, and assesses tissue perfusion through photoplethysmography. This multi-functional approach eliminates the need for separate monitoring devices and provides comprehensive patient assessment
2Measurement precision
If pulse oximeter is used for hemodynamic monitoring, then tissue perfusion information can be obtained, but cardiac electrophysiology signals cannot be captured
Solution Approach 1:
The patent integrates pulse oximeter sensors with ECG electrodes in a single monitoring system. The pulse oximeter component continuously measures tissue perfusion and pulse waveform characteristics while the co-located ECG electrodes simultaneously capture cardiac electrophysiology signals, ensuring neither information source is lost
3Device complexity
If traditional monitoring methods are used, then device complexity is low, but early detection of pre-symptomatic bradycardia is difficult
Solution Approach 1:
The system continuously analyzes pulse waveform features including amplitude, morphology, and temporal characteristics, comparing them against baseline values and threshold criteria. When anomalies detected in pulse rate differences or pulse strength differences exceed predetermined thresholds, the system generates alerts for pre-symptomatic bradycardia, enabling early intervention while maintaining relatively simple device architecture
Solution Approach 2:
The monitoring system establishes baseline pulse waveform characteristics during normal physiological conditions and uses these baselines to detect deviations before symptomatic bradycardia occurs. By continuously comparing real-time pulse metrics against predetermined threshold limits, the system identifies pre-symptomatic changes in tissue perfusion and cardiac function, enabling proactive clinical intervention
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables early detection and quantification of cardiac bradycardia, allowing for timely intervention in hypovolemic hypotensive conditions, thereby improving patient management and reducing the risk of hemodynamic instability.
Implementation Method 1
The photoplethysmograph is not capable of capturing electrophysiological signals. However, measures derived from the pulse waveform can be used to assess changes in tissue perfusion and autonomic nervous system stress patterns based upon temporal alterations of the pulse waveform features.
Data Source
AI summary
A method for identifying cardiac bradiacardia behavior may include acquiring pulse volume wave data from a sensor associated with a patient, and calculating metrics associated with peaks detected therein. The metrics may include changes in peak amplitudes of pulse volume peaks and in the times of occurrence of pulse volume peaks. Alternative metrics may include changes in frequency domain parameters derived from the time domain pulse volume wave data. Peak amplitude values may be compared to an amplitude baseline, and differences in successive peak occurrence times may be compared to a time baseline. Cardiac bradycardia behavior may be identified by a combination of a decrease in the pulse volume peak amplitude and an increase in successive peak occurrence times. A system to implement the method may include a computing device in data communication with a photo-plethysmograph. Alternative sensors may include a blood pressure cuff and an ECG device.